Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Por Balow, J E, Hurley, D L, Fauci, A S
Publicado em 1975

Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.

Por Fauci, A S, Balow, J E, Pratt, K R
Publicado em 1976

Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.

Por Balow, J E, Parrillo, J E, Fauci, A S
Publicado em 1977

Concanavalin-induced suppressor cells: characterization on the basis of corticosteroid and radiation sensitivity.

Por Tsokos, G C, Christian, C B, Balow, J E
Publicado em 1982

Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders.

Por Djeu, J Y, Kasahara, T, Balow, J E, Tsokos, G C
Publicado em 1986

Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry.

Por Inghirami, G, Nakamura, M, Balow, J E, Notkins, A L, Casali, P
Publicado em 1988

Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity.

Por Bernstein, K A, Kahl, L E, Balow, J E, Lefkowith, J B
Publicado em 1994

Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

Por Tsokos, G C, Rook, A H, Djeu, J Y, Balow, J E
Publicado em 1982

Regulation of immunoglobulin secretion by factor H of human complement.

Por Tsokos, G C, Inghirami, G, Tsoukas, C D, Balow, J E, Lambris, J D
Publicado em 1985

Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.

Por Miller, F W, Love, L A, Barbieri, S A, Balow, J E, Plotz, P H
Publicado em 1990

Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.

Por Tsokos, G C, Balow, J E, Huston, D P, Wei, N, Decker, J L
Publicado em 1982

Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.

Por Boumpas, D T, Anastassiou, E D, Older, S A, Tsokos, G C, Nelson, D L, Balow, J E
Publicado em 1991

Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies

Por Malek, R., Chong, A. Y., Lupsa, B. C., Lungu, A. O., Cochran, E. K., Soos, M. A., Semple, R. K., Balow, J. E., Gorden, P.
Publicado em 2010

Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.

Por Levy, E. N., Shen, Y., Kupelian, A., Kruglyak, L., Aksentijevich, I., Pras, E., Balow, J. E., Linzer, B., Chen, X., Shelton, D. A., Gumucio, D., Pras, M., Shohat, M., Rotter, J. I., Fischel-Ghodsian, N., Richards, R. I., Kastner, D. L.
Publicado em 1996